Golidocitinib 1-hydroxy-2-naphthoate
Product Specifications
CAS Number
2091134-68-6 (free base)
Target
JAK
Applications
Angiogenesis
Additionnal Information
Golidocitinib 1-hydroxy-2-naphthoate is a derivative of Golidocitinib, an oral, potent, selective inhibitor of Janus kinase 1 (JAK1) with an IC50 of 70 nM. It exhibits enhnaced antitumor activity and can be used for the treatment of cancer, including peripheral T cell lymphoma (PTCL) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-339029 250 mg
1-methyl-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylic acid
Sign In for Pricing
View Details orb2919402-01 20 µg
Recombinant CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (pgsA)
Sign In for Pricing
View Details orb2919402-02 100 µg
Recombinant CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (pgsA)
Sign In for Pricing
View Details 
bsm-2118M-BF647 100 µL
HHb (H5A3) Monoclonal Antibody, AbBy Fluor™ 647 Conjugated
Sign In for Pricing
View Details